Key terms

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ILMN news

Yesterday 8:18am ET Piper Sandler Keeps Their Buy Rating on Illumina (ILMN) by TipRanks Yesterday 8:05am ET Illumina price target lowered to $195 from $200 at Evercore ISI by TipRanks Yesterday 7:46am ET Illumina price target lowered to $140 from $151 at TD Cowen by TipRanks Yesterday 7:04am ET RBC Capital Keeps Their Buy Rating on Illumina (ILMN) by TipRanks Yesterday 6:22am ET Wall Street Analysts Are Bearish on Top Healthcare Picks by TipRanks Yesterday 6:22am ET Illumina price target raised to $128 from $125 at Baird by TipRanks May 02 4:08pm ET Illumina sees FY24 core revenue flat vs. FY23, consensus $4.51B by TipRanks May 02 4:07pm ET Illumina reports Q1 EPS 9c, consensus 4c by TipRanks May 02 1:49pm ET Notable companies reporting after market close by TipRanks Apr 30 9:49pm ET RBC Capital Reaffirms Their Buy Rating on Illumina (ILMN) by TipRanks Apr 29 11:29am ET Baird says FDA final LDT rule favorable for Life Sciences, Diagnostics coverage by TipRanks Apr 12 10:00am ET Illumina $1B cash outlay for Grail divestment ‘better than fears,’ says Evercore by TipRanks Apr 12 9:12am ET Illumina Gains Approval for GRAIL Divestiture Plans by TipRanks Apr 12 9:01am ET Illumina’s planned divestment of GRAIL approved by European Commission by TipRanks Apr 12 1:39am ET Illumina (ILMN) Maintains Strong Guidance and Strategic Leadership Appointments by TipRanks Apr 09 4:34pm ET Illumina Announces Executive Shift and New CFO Appointment by TipRanks Apr 08 9:45pm ET RBC Capital Sticks to Its Buy Rating for Illumina (ILMN) by TipRanks Apr 04 5:40am ET Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and Humana (HUM) by TipRanks Mar 22 7:17am ET Illumina’s Stock Rating Maintained at Hold Amid Legal Uncertainties and Regulatory Challenges by TipRanks Mar 21 9:56am ET Early notable gainers among liquid option names on March 21st by TipRanks Mar 21 8:51am ET EU opinion could mean Illumina no longer required to fund GRAIL, says Guggenheim by TipRanks Mar 20 9:38am ET Illumina downgraded to Mixed from Positive view at OTR Global by TipRanks Mar 19 9:55am ET Early notable gainers among liquid option names on March 19th by TipRanks Mar 19 5:50am ET Analysts Conflicted on These Healthcare Names: Illumina (ILMN) and Elevance Health (ELV) by TipRanks Mar 15 9:39am ET China stimulus positive for GE HealthCare, tool companies, says Evercore ISI by TipRanks Mar 12 2:06pm ET Icahn drops threat to challenge Illumina board, Reuters reports by TipRanks Mar 12 2:03pm ET Icahn drops threat to challenge Illumina board, Reuters reports by TipRanks Mar 11 2:40am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), MoonLake Immunotherapeutics (MLTX) and Wave Life Sciences (WVE) by TipRanks Feb 26 9:55am ET Early notable gainers among liquid option names on February 26th by TipRanks Feb 21 6:10am ET Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and Globus Medical (GMED) by TipRanks Feb 15 7:20am ET Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), SAGE Therapeutics (SAGE) and Illumina (ILMN) by TipRanks
Apr 29 12:45pm ET Inspiring Young Minds: HRH the Princess Royal Helps Illumina Celebrate DNA Day by Accesswire Apr 18 1:30pm ET Engineering a Cool Career in Biotech - and Volunteering Along the Way by Accesswire Apr 17 9:30am ET Evidence Supports Sequencing As First-Line Rare Disease Diagnostic by Accesswire Apr 05 12:45pm ET Why More Clinical Labs Are Turning to Whole-Genome Sequencing for Cancer by Accesswire Apr 02 9:45am ET Giving Students a New Window on Genomic Technologies by Accesswire Mar 18 12:40pm ET A Biobank for the Americas and a Genomics Lab Power Precision Health for All by Accesswire

ILMN Financials

1-year income & revenue

Key terms

ILMN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ILMN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Warren Buffett (L), CEO of Berkshire Hathaway, and Vice Chairman Charlie Munger attend the 2019 annual shareholders meeting in Omaha, Nebraska, May 3, 2019.
Johannes Eisele/AFP/Getty Images
Warren Buffett holds first Berkshire Hathaway meeting without Charlie Munger
People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stocks close higher after softer-than-expected jobs report fuels hopes of an earlier rate cut
People work at a Starbucks in Manhattan on February 02, 2024 in New York City.
Spencer Platt/Getty Images
Restaurants are competing for frugal diners’ dollars
Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City.
Michael M. Santiago/Getty Images/File
Sell in May and go away? Think again